Paper7054072
Drugs as indicators of hepatic function.
Branch RA. Hepatology, 1982. Cited by 140 papers, by iCite.
Cite this record
ConductScience Library. Drugs as indicators of hepatic function. Papers, record 7054072. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7054072
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diagnostic Uses of Chemicals | Major topic |
| Liver | Major topic |
| Pharmaceutical Preparations | Major topic |
| Aminopyrine | |
| Breath Tests | |
| Diazepam | |
| Half-Life | |
| Humans | |
| Indocyanine Green | |
| Liver Function Tests | |
| Propranolol |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| GM-15431 | NIGMS NIH HHS | United States | P11GM015431 | PubMed and NIH | NIH RePORTER |
| P50GM015431 | NIH | NIH RePORTER |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30778701 | Navigation surgery using indocyanine green fluorescent imaging for hepatoblastoma patients. | Pediatr Surg Int | 2019 | https://conductscience.org/library/papers/30778701 | PubMed |
| 30561406 | Fluorescence guided surgery in liver tumors: applications and advantages. | Acta Biomed | 2018 | https://conductscience.org/library/papers/30561406 | PubMed |
| 17328584 | Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis. | Clin Pharmacokinet | 2007 | https://conductscience.org/library/papers/17328584 | PubMed |
| 10219839 | Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations. | Dig Dis Sci | 1999 | https://conductscience.org/library/papers/10219839 | PubMed |
| 9592620 | The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9592620 | PubMed |
| 8491059 | Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8491059 | PubMed |
| 8261817 | Hepatic [14C]aminopyrine demethylation capacity after portocaval shunting. Comparative study in patients with and without arterialization of portal vein. | Dig Dis Sci | 1993 | https://conductscience.org/library/papers/8261817 | PubMed |
| 8261816 | Effect of lidocaine on in vivo hepatic function. | Dig Dis Sci | 1993 | https://conductscience.org/library/papers/8261816 | PubMed |
| 7988103 | Assessment of liver metabolic function. Clinical implications. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/7988103 | PubMed |
| 7550858 | Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity. | J Gastroenterol | 1995 | https://conductscience.org/library/papers/7550858 | PubMed |
| 6529530 | Drug metabolism in diabetic subjects with fatty livers. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6529530 | PubMed |
| 6508980 | Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6508980 | PubMed |
| 6426645 | Detection of hepatitis B virus DNA in mononuclear blood cells. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6426645 | PubMed |
| 6362950 | First-pass elimination. Basic concepts and clinical consequences. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6362950 | PubMed |
| 6143671 | Assessment of drug metabolism in hepatic disease: comparison of plasma kinetics of oral cyclobarbital and the intravenous aminopyrine breath test. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6143671 | PubMed |
| 6142865 | Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives. | Int Arch Occup Environ Health | 1984 | https://conductscience.org/library/papers/6142865 | PubMed |
| 3928286 | [14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis. | Dig Dis Sci | 1985 | https://conductscience.org/library/papers/3928286 | PubMed |
| 3691613 | The disposition and metabolism of (+)-cyanidanol-3 in patients with alcoholic cirrhosis. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3691613 | PubMed |
| 3567052 | Age-related changes in trimethadione oxidizing capacity. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3567052 | PubMed |
| 3325214 | Clinical pharmacokinetics and endocrine disorders. Therapeutic implications. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3325214 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7054072
GET https://conductscience.org/api/papers/v1/7054072/cited_by?page=2